Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02595866
Brief Title: Pembrolizumab in Treating Patients With HIV and Relapsed, Refractory, or Disseminated Malignant Neoplasms

First Submitted : November 3, 2015
First Submitted that Met QC Criteria : November 3, 2015
First Posted : November 4, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : January 7, 2021
Last Update Posted : January 8, 2021